Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study

BACKGROUND: Recent studies have highlighted the possible risk of neuropsychiatric adverse effects during treatment with lipid-lowering medications. However, there are still controversies that require a novel genetic-based approach to verify whether the impact of lipid-lowering drug treatment results...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Jahad, Matou-Nasri, Sabine, Alghamdi, Faisal, Alghamdi, Saleh, Alfadhel, Majid, Padmanabhan, Sandosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Regular Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276028/
https://www.ncbi.nlm.nih.gov/pubmed/29986042
http://dx.doi.org/10.1093/ijnp/pyy060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276028/
https://www.ncbi.nlm.nih.gov/pubmed/29986042
http://dx.doi.org/10.1093/ijnp/pyy060

Ejemplares similares